Medication info
Minirin Tablet 0.2 mg (Desmopressin Acetate)

Minirin Tablet 0.2 mg (Desmopressin Acetate)

Prescription medicationTabletOral
Ingredient · strength
Desmopressin Acetate›0.2mg / 1 tablet
Manufacturer / importer
Ferring Pharmaceuticals Korea Co., Ltd.
Appearance
White, convex, round tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 199504250 · Notified 1995.04.21 · Insurance code 652500130

Summary

Main use
Treatment of primary nocturnal enuresis (age 5 years and older) and nocturia associated with nocturnal polyuria (adults)
Who takes it
Adults · Children
Adult dose
Treatment of nocturia associated with nocturnal polyuria (adults only) Administer 0.1mg of desmopressin acetate orally at bedtime. If the effect is insufficient after one week, increase the dose to 0.2mg. If the effect remains insufficient, increase the dose at one-week intervals up to 0.4mg. Discontinue treatment if there is no clinical effect within 4 weeks after dose determination. Initiation of treatment with this drug is not recommended in patients aged 65 years or older. If treatment is required in older patients, closely monitor serum sodium levels, etc. (see 5. General precautions under Precautions for use).
Child dose
Primary nocturnal enuresis (5 years of age and older): Administer 0.2mg of desmopressin acetate orally at bedtime. If the effect is insufficient, the dose may be increased to 0.4mg. The decision to continue treatment should be made after 3 months of administration, following a treatment-free period of at least 1 week.

Ingredients

Importer
Ferring Pharmaceuticals Korea Co., Ltd.

Efficacy & effects

Treatment of primary nocturnal enuresis (age 5 years and older) and nocturia associated with nocturnal polyuria (adults)

  • Primary nocturnal enuresis
  • nocturia symptoms
View approved original text

This medication is used to treat primary nocturnal enuresis in children aged 5 years and older and nocturia symptoms related to nocturia in adults. In other words, it helps improve the problem of frequent urination at night.

How to take

Adult dose

Treatment of nocturia associated with nocturnal polyuria (adults only) Administer 0.1mg of desmopressin acetate orally at bedtime. If the effect is insufficient after one week, increase the dose to 0.2mg. If the effect remains insufficient, increase the dose at one-week intervals up to 0.4mg. Discontinue treatment if there is no clinical effect within 4 weeks after dose determination. Initiation of treatment with this drug is not recommended in patients aged 65 years or older. If treatment is required in older patients, closely monitor serum sodium levels, etc. (see 5. General precautions under Precautions for use).

Child dose

Primary nocturnal enuresis (5 years of age and older): Administer 0.2mg of desmopressin acetate orally at bedtime. If the effect is insufficient, the dose may be increased to 0.4mg. The decision to continue treatment should be made after 3 months of administration, following a treatment-free period of at least 1 week.

Precautions

This medication helps regulate the body's fluid balance and can cause hyponatremia and water intoxication, especially in the elderly or patients with certain diseases, so it is important to limit fluid intake to the point of feeling thirsty. It should not be administered to those with hypersensitivity to this drug, severe renal failure, congestive heart failure, specific neurological disorders, or patients taking diuretics, and individuals with genetic lactose intolerance should also avoid taking it. Use with caution in patients with hypertension, chronic kidney disease, women of childbearing potential, children, the elderly, and patients at risk of fluid or electrolyte imbalance. While taking this medication, side effects such as headaches, nausea, seizures, and weight gain may occur, with a higher risk of hyponatremia in the elderly, necessitating regular blood tests. Fluid intake should be restricted for a certain period before and after taking this medication; failure to observe this can lead to serious side effects. Additionally, interactions may occur when used with other medications, so those medications should definitely be discussed with healthcare professionals. Women who are pregnant or breastfeeding need to be cautious when using this medication, and it is generally advisable to avoid it during breastfeeding. In case of overdose, symptoms such as headaches, seizures, and loss of consciousness may appear, so immediate medical help should be sought, and treatment such as fluid restriction and diuretics may be necessary.

Side effects

  • coma
  • seizures
  • weight gain
  • hyponatremia
  • allergic reactions
  • emotional disturbances
  • headache
  • abdominal pain
  • nausea
  • allergic skin reactions
Show 9 more
  • dizziness
  • peripheral edema
  • increased urine output
  • dry mouth
  • anaphylaxis
  • vomiting
  • weight increase
  • cold sensation
  • loss of consciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to store it at room temperature, not too hot or too cold.

Appearance and packaging

Appearance

White, convex, round tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.